Skip to main content

EDITORIAL article

Front. Immunol.
Sec. Multiple Sclerosis and Neuroimmunology
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1469614
This article is part of the Research Topic Comorbidity in Multiple Sclerosis and Related Disorders View all 9 articles

Editorial: Comorbidity in Multiple Sclerosis and Related Disorders

Provisionally accepted
Mahdi Barzegar Mahdi Barzegar 1*Jelena S. Drulovic Jelena S. Drulovic 2Viviana Nociti Viviana Nociti 3
  • 1 Isfahan University of Medical Sciences, Isfahan, Iran
  • 2 University of Belgrade, Belgrade, Serbia
  • 3 Fondazione Policlinico Universitario, Rome, Italy

The final, formatted version of the article will be published soon.

    Keywords: multiple scleorsis, Comorbidity, neuromyelities optica spectrum disorders, CNS demyelinating diseases, Autoimmune Diseases

    Received: 24 Jul 2024; Accepted: 30 Jul 2024.

    Copyright: © 2024 Barzegar, Drulovic and Nociti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Mahdi Barzegar, Isfahan University of Medical Sciences, Isfahan, Iran

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.